NKTR – Nektar Therapeutics
Float Short %
5.54
Margin Of Safety %
Put/Call OI Ratio
0.6
EPS Next Q Diff
-0.6
EPS Last/This Y
-1.98
EPS This/Next Y
-1
Price
27.04
Target Price
96.17
Analyst Recom
1.75
Performance Q
173.03
Relative Volume
0.64
Beta
-1.01
Ticker: NKTR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | NKTR | 25.02 | 0.25 | 0.11 | 59984 |
| 2025-07-28 | NKTR | 23.65 | 0.25 | 1.12 | 60990 |
| 2025-07-29 | NKTR | 22.91 | 0.25 | 2.91 | 61442 |
| 2025-07-30 | NKTR | 22.14 | 0.27 | 0.90 | 62787 |
| 2025-07-31 | NKTR | 21.71 | 0.28 | 0.35 | 63905 |
| 2025-08-01 | NKTR | 22.88 | 0.28 | 0.16 | 64164 |
| 2025-08-04 | NKTR | 23.27 | 0.28 | 0.06 | 64884 |
| 2025-08-05 | NKTR | 22.59 | 0.28 | 2.23 | 65353 |
| 2025-08-06 | NKTR | 22.51 | 0.29 | 0.19 | 65808 |
| 2025-08-07 | NKTR | 21.66 | 0.29 | 0.62 | 66047 |
| 2025-08-08 | NKTR | 22.96 | 0.29 | 0.10 | 66307 |
| 2025-08-11 | NKTR | 22.51 | 0.29 | 0.79 | 65521 |
| 2025-08-12 | NKTR | 23.62 | 0.29 | 0.45 | 65678 |
| 2025-08-13 | NKTR | 25.69 | 0.29 | 0.30 | 65473 |
| 2025-08-14 | NKTR | 26.74 | 0.27 | 0.32 | 74727 |
| 2025-08-15 | NKTR | 27.3 | 0.27 | 0.04 | 74650 |
| 2025-08-18 | NKTR | 27.42 | 0.60 | 0.55 | 25368 |
| 2025-08-19 | NKTR | 26.78 | 0.60 | 0.44 | 26253 |
| 2025-08-20 | NKTR | 26.95 | 0.60 | 1.23 | 26439 |
| 2025-08-21 | NKTR | 28 | 0.60 | 0.23 | 26463 |
| 2025-08-22 | NKTR | 27.07 | 0.60 | 0.45 | 26800 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | NKTR | 25.00 | 0.7 | - | -10.01 |
| 2025-07-28 | NKTR | 23.69 | -11.1 | - | -10.01 |
| 2025-07-29 | NKTR | 22.91 | -11.1 | - | -10.01 |
| 2025-07-30 | NKTR | 22.07 | -11.1 | - | -10.01 |
| 2025-07-31 | NKTR | 21.68 | -11.1 | - | -10.01 |
| 2025-08-01 | NKTR | 22.96 | -11.1 | - | -10.01 |
| 2025-08-04 | NKTR | 23.27 | -11.1 | - | -10.01 |
| 2025-08-05 | NKTR | 22.56 | -11.1 | - | -10.01 |
| 2025-08-06 | NKTR | 22.50 | -11.1 | - | -10.01 |
| 2025-08-07 | NKTR | 21.75 | -11.1 | - | -10.01 |
| 2025-08-08 | NKTR | 23.06 | -11.1 | - | -10.01 |
| 2025-08-11 | NKTR | 22.48 | -11.1 | - | -10.01 |
| 2025-08-12 | NKTR | 23.59 | 1.4 | - | -10.01 |
| 2025-08-13 | NKTR | 25.72 | 1.4 | - | -10.01 |
| 2025-08-14 | NKTR | 26.74 | 1.4 | - | -10.01 |
| 2025-08-15 | NKTR | 27.27 | 1.4 | - | -10.68 |
| 2025-08-18 | NKTR | 27.47 | -14.0 | - | -10.68 |
| 2025-08-19 | NKTR | 26.72 | -14.0 | - | -10.68 |
| 2025-08-20 | NKTR | 26.96 | -14.0 | - | -10.68 |
| 2025-08-21 | NKTR | 27.92 | -14.0 | - | -10.68 |
| 2025-08-22 | NKTR | 27.04 | -14.0 | - | -10.68 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | NKTR | -16.79 | 27.61 | 6.91 |
| 2025-07-28 | NKTR | -16.79 | 36.29 | 6.91 |
| 2025-07-29 | NKTR | -16.79 | 36.29 | 6.91 |
| 2025-07-30 | NKTR | -16.79 | 36.29 | 6.91 |
| 2025-07-31 | NKTR | -16.79 | 36.29 | 6.91 |
| 2025-08-01 | NKTR | -16.79 | 36.29 | 6.91 |
| 2025-08-04 | NKTR | -16.79 | 43.23 | 6.91 |
| 2025-08-05 | NKTR | -16.79 | 43.23 | 6.91 |
| 2025-08-06 | NKTR | -16.79 | 43.23 | 6.91 |
| 2025-08-07 | NKTR | -16.79 | 43.23 | 6.91 |
| 2025-08-08 | NKTR | -16.79 | 43.23 | 6.91 |
| 2025-08-11 | NKTR | -16.79 | 43.42 | 6.91 |
| 2025-08-12 | NKTR | -16.79 | 43.42 | 6.09 |
| 2025-08-13 | NKTR | -16.79 | 43.42 | 5.54 |
| 2025-08-14 | NKTR | -15.51 | 43.42 | 5.54 |
| 2025-08-15 | NKTR | -15.51 | 43.42 | 5.54 |
| 2025-08-18 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-19 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-20 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-21 | NKTR | -15.51 | 31.02 | 5.54 |
| 2025-08-22 | NKTR | -8.82 | 31.02 | 5.54 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-2.95
Avg. EPS Est. Current Quarter
-3.02
Avg. EPS Est. Next Quarter
-3.54
Insider Transactions
-8.82
Institutional Transactions
31.02
Beta
-1.01
Average Sales Estimate Current Quarter
10
Average Sales Estimate Next Quarter
10
Fair Value
Quality Score
25
Growth Score
23
Sentiment Score
81
Actual DrawDown %
93.3
Max Drawdown 5-Year %
-98.3
Target Price
96.17
P/E
Forward P/E
PEG
P/S
6.86
P/B
P/Free Cash Flow
EPS
-8.72
Average EPS Est. Cur. Y
-10.68
EPS Next Y. (Est.)
-11.68
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-163.17
Relative Volume
0.64
Return on Equity vs Sector %
480.3
Return on Equity vs Industry %
493.2
EPS 1 7Days Diff
-0.7
EPS 1 30Days Diff
0.46
EBIT Estimation
Nektar TherapeuticsSector: Healthcare
Industry: Biotechnology
Employees: 61
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.
stock quote shares NKTR – Nektar Therapeutics Stock Price stock today
news today NKTR – Nektar Therapeutics stock forecast ,stock prediction 2023 2024 2025
marketwatch NKTR – Nektar Therapeutics yahoo finance google finance
stock history NKTR – Nektar Therapeutics invest stock market
stock prices NKTR premarket after hours
ticker NKTR fair value insiders trading